MSCT在原发性肝癌诊断及TACE治疗效果评价中的应用研究
DOI:
CSTR:
作者:
作者单位:

新郑华信民生医院影像科

作者简介:

通讯作者:

中图分类号:

基金项目:


Application of MSCT in the diagnosis of primary liver cancer and the evaluation of TACE therapeutic effect
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探究多层螺旋CT(MSCT)在原发性肝癌诊断及经导管动脉化疗栓塞(TACE)治疗效果评价中的应用价值。方法:选取2022年5月至2025年6月医院收治的79例肝脏占位性病变患者,均接受MSCT检查,以病理结果为诊断金标准,分析MSCT对原发性肝癌诊断的诊断价值及评价TACE治疗效果的效能。结果:79例患者,病理诊断结果显示原发性肝癌(肝癌组)62例;MSCT诊断原发性肝癌的敏感度、特异度、准确度分别为93.55%(58/62)、94.12%(16/17)、93.67(74/79),与病理诊断的一致性良好(kappa值=0.824)。TACE治疗后,62例原发性肝癌患者肝血流量、肝动脉灌注量及平均通过时间均明显低于治疗前(P<0.05),达峰时间明显高于治疗前(P<0.05)。TACE治疗后,有效组40例,无效组22例;有效组肝血流量、肝动脉灌注量及平均通过时间均明显低于无效组(P<0.05),达峰时间明显高于无效组(P<0.05)。ROC曲线显示,MSCT各参数联合评价原发性肝癌患者TACE治疗效果的AUC为0.964(P<0.05),联合评价效能更高。结论:MSCT可直观反映患者病灶血供情况,用其诊断原发性肝癌的结果与病理诊断的一致性良好,且对评价TACE治疗效果有显著价值。

    Abstract:

    Objective: To explore the application value of multi-slice spiral CT (MSCT) in the diagnosis of primary liver cancer and the evaluation of therapeutic effect of transcatheter arterial chemoembolization (TACE). Methods: A total of 79 patients with liver space-occupying lesions admitted to the hospital from May 2022 to June 2025 were selected. All patients underwent MSCT examination. The pathological result was used as the gold standard for diagnosis, and the diagnostic value of MSCT in the diagnosis of primary liver cancer and the efficiency on evaluating the therapeutic effect of TACE were analyzed. Results: Among the 79 patients, pathological diagnosis showed 62 cases of primary liver cancer (liver cancer group). The sensitivity, specificity and accuracy of MSCT in the diagnosis of primary liver cancer were 93.55% (58/62), 94.12% (16/17) and 93.67% (74/79) respectively, revealing a good consistency with pathological diagnosis (kappa=0.824). After TACE treatment, the hepatic blood flow volume, hepatic artery perfusion volume and mean transit time of 62 patients with primary liver cancer were significantly less or shorter than those before treatment (P<0.05), and the time to peal was significantly longer than that before treatment (P<0.05). After TACE treatment, there were 40 cases in effective group and 22 cases in ineffective group. The hepatic blood flow volume, hepatic artery perfusion volume and mean transit time in effective group were significantly less or shorter (P<0.05), and the time to peak was significantly longer compared to ineffective group (P<0.05). ROC curve showed that the AUC of the combination of MSCT parameters for evaluating the therapeutic effect of TACE in patients with primary liver cancer was 0.964 (P<0.05), and combined evaluation had higher efficiency. Conclusion: MSCT can directly reflect the blood supply status of lesions. The results of its diagnosis of primary liver cancer show a good consistency with pathological diagnosis, and it has significant value on evaluating the therapeutic effect of TACE.

    参考文献
    相似文献
    引证文献
引用本文

邢晓艳. MSCT在原发性肝癌诊断及TACE治疗效果评价中的应用研究[J].四川生理科学杂志,2026,48(8):

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2026-02-03
  • 最后修改日期:2026-02-27
  • 录用日期:2026-03-07
  • 在线发布日期: 2026-08-15
  • 出版日期:
文章二维码